October 19, 2023 — A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.   

October 19, 2023 — Alexandra Touroutoglou, PhD, and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital, are the lead a

October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body.

October 19, 2023 —NewVue, Inc., in seeking to address the medical imaging community’s growing radiologist shortage and high-stress culture, has announced the unveiling of EmpowerSuite.

October 18, 2023 — DeepTek.ai, a leading medical imaging AI company in India has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its revolutionary Chest X-ray AI solution - CXR Analyzer.

October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage with evidence development (CED) for beta-amyloid 

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-

October 17, 2023 — Thymus, a small and relatively unknown organ, may play a bigger role in the immune system of adults than was previously believed. With age, the glandular tissue in the thymus is replaced by fat, but, according to a new study from Linköping University (LiU) in Sweden, the rate at which this happens is linked to sex, age and lifestyle factors. These findings also indicate that the appearance of the thymus reflects the ageing of the immune system. 

October 17, 2023 — Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now